[HTML][HTML] The laboratory rat: Age and body weight matter

A Ghasemi, S Jeddi, K Kashfi - EXCLI journal, 2021 - ncbi.nlm.nih.gov
Animal experimentation helps us to understand human biology. Rodents and, in particular,
rats are among the most common animals used in animal experiments. Reporting data on …

[HTML][HTML] Quercetin as an agent for protecting the bone: a review of the current evidence

SK Wong, KY Chin, S Ima-Nirwana - International journal of molecular …, 2020 - mdpi.com
Quercetin is a flavonoid abundantly found in fruits and vegetables. It possesses a wide
spectrum of biological activities, thus suggesting a role in disease prevention and health …

Unraveling female reproductive senescence to enhance healthy longevity

L Dong, DBL Teh, BK Kennedy, Z Huang - Cell Research, 2023 - nature.com
In a society where women often want successful careers and equal opportunities to men, the
early nature of ovarian aging often forces women to make difficult life choices between …

[HTML][HTML] Pharmaceutical treatment of bone loss: From animal models and drug development to future treatment strategies

MB Brent - Pharmacology & Therapeutics, 2023 - Elsevier
Animal models are fundamental to advance our knowledge of the underlying
pathophysiology of bone loss and to study pharmaceutical countermeasures against it. The …

Improvement of aqueous stability and anti-osteoporosis properties of Zn-MOF coatings on titanium implants by hydrophobic raloxifene

X Shen, KHR Yie, X Wu, Z Zhou, A Sun… - Chemical Engineering …, 2022 - Elsevier
Endowed with superior tailorability and functionality, metal–organic frameworks (MOFs)
have been exploited for their diverse applications in biomedicine. However, the instability of …

[HTML][HTML] Exosomal miR-186 derived from BMSCs promote osteogenesis through hippo signaling pathway in postmenopausal osteoporosis

L Li, X Zhou, J Zhang, A Liu, C Zhang, J Han… - Journal of Orthopaedic …, 2021 - Springer
Background Postmenopausal osteoporosis (PMO) that results from estrogen withdrawal is
the most common primary osteoporosis among older women. However, little is known about …

[HTML][HTML] A review on the molecular mechanisms of action of natural products in preventing bone diseases

IU Okagu, TPC Ezeorba, RN Aguchem… - International Journal of …, 2022 - mdpi.com
The drugs used for treating bone diseases (BDs), at present, elicit hazardous side effects
that include certain types of cancers and strokes, hence the ongoing quest for the discovery …

[HTML][HTML] Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis

J Taubmann, B Krishnacoumar, C Böhm, M Faas… - Scientific reports, 2020 - nature.com
Osteoclasts are specialised bone resorbing cells that control both physiological and
pathological bone turnover. Functional changes in the differentiation and activity of …

[HTML][HTML] Gold-nanosphere mitigates osteoporosis through regulating TMAO metabolism in a gut microbiota-dependent manner

Y Chen, C Yang, Q Dai, J Tan, C Dou, F Luo - Journal of …, 2023 - Springer
Osteoporosis (OP) is a metabolic bone disease characterized by decreased bone mass and
increased bone fragility. The imbalance of bone homeostasis modulated by osteoclasts and …

[HTML][HTML] Analysis and validation of hub genes in blood monocytes of postmenopausal osteoporosis patients

YX Deng, WG He, HJ Cai, JH Jiang, YY Yang… - Frontiers in …, 2022 - frontiersin.org
Osteoporosis is a common systemic bone disease caused by the imbalance between
osteogenic activity and osteoclastic activity. Aged women are at higher risk of osteoporosis …